Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.

The progression of podocytopathies is quite variable among patients and the underlying reason for this remains unclear. Here, we report that autophagic activity in podocytes plays a critical role in controlling the progression of podocytopathies. Morphological and biochemical studies on renal biopsies from patients with minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS) showed that glomeruli, and in particular podocytes, from MCD patients had higher levels of Beclin1-mediated autophagic activity than glomeruli from FSGS patients. Repeat renal biopsies of MCD patients enabled tracking of podocyte autophagic activity and confirmed that patients maintaining high podocyte autophagic activity retained MCD status, whereas patients with decreased podocyte autophagic activity progressed to FSGS. Inhibition of autophagic activity, by knocking down Beclin1 or by treating with 3-methyladenine (3-MA) or chloroquine, enhanced puromycin aminonucleoside (PAN)-induced apoptosis of podocytes. In contrast, rapamycin-mediated promotion of autophagic activity decreased this apoptosis. In PAN-treated rats, inhibition of autophagy with 3-MA or chloroquine resulted in earlier onset and greater proteinuria, more extensive foot-process effacement, and reduction in podocyte markers, whereas rapamycin-mediated stimulation of autophagy led to decreased proteinuria and less severe foot-process effacement, but higher expression of podocyte markers. This study demonstrates that podocyte autophagic activity plays a critical protective role in renal injury and that maintaining podocyte autophagic activity represents a potential therapeutic strategy for controlling the progression of podocytopathies.
AuthorsCaihong Zeng, Yun Fan, Junnan Wu, Shaolin Shi, Zhaohong Chen, Yongzhong Zhong, Changming Zhang, Ke Zen, Zhihong Liu
JournalThe Journal of pathology (J Pathol) Vol. 234 Issue 2 Pg. 203-13 (Oct 2014) ISSN: 1096-9896 [Electronic] England
PMID24870816 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Chemical References
  • Puromycin Aminonucleoside
  • Acute Kidney Injury (metabolism, pathology, physiopathology)
  • Animals
  • Apoptosis (physiology)
  • Autophagy (physiology)
  • Disease Models, Animal
  • Disease Progression
  • Female
  • Glomerulosclerosis, Focal Segmental (chemically induced, metabolism, physiopathology)
  • Humans
  • Male
  • Podocytes (drug effects, metabolism)
  • Proteinuria (metabolism)
  • Puromycin Aminonucleoside (pharmacology)
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: